Israel
DiA Imaging Analysis, a prominent name in the intersection of AI and Health Care, primarily focuses on leveraging artificial intelligence to enhance the efficiency and accessibility of ultrasound image analysis. Founded in 2009 and headquartered in Israel, the company has distinguished itself as a frontrunner in the development of FDA-cleared and CE-marked ultrasound AI software.
Their flagship LVivo product line, particularly notable for automating cardiac and abdominal image analysis, caters to clinicians irrespective of their ultrasound proficiency. LVivo Seamless™, renowned for its automatic selection and analysis capabilities, enhances clinical productivity by delivering critical measurements with high precision.
DiA's innovations have been widely recognized, earning a place among Fast Company's 2022 World Changing Ideas and named by CB Insights as a digital health innovator. In 2023, the company was acquired by Philips, following a $14.00M investment round in August 2021 where prominent investors such as Connecticut Innovations, Alchimia Investments, and Philips Venture Capital Fund participated.
